Serina Therapeutics (SER) executive Moreadith sold 6,500 shares for $23.5K at an average $3.61
Insider transactions reported
Randall Moreadith (Chief Scientific Officer at Serina Therapeutics Inc., SER) reported that they sold 6,500 shares for $23.5K at an average $3.61, and acquired 6,500 shares at $0.06 between Dec 2, 2025 and Dec 3, 2025. After these transactions the filing shows 0 shares held directly.
- Reporting person
- Moreadith Randall
- Role
- Chief Scientific Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 2, 2025 | Exercise or conversion of a derivative (M) | Common Stock | +1,500 | $0.06 | $90 | 1,500 direct |
| Dec 2, 2025 | Open-market sale (S) | Common Stock1 | -1,500 | $3.91 | $5,858 | 0 direct |
| Dec 3, 2025 | Exercise or conversion of a derivative (M) | Common Stock | +5,000 | $0.06 | $300 | 5,000 direct |
| Dec 3, 2025 | Open-market sale (S) | Common Stock2 | -5,000 | $3.52 | $17.6K | 0 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 2, 2025 | Exercise or conversion of a derivative (M) | Stock Option (right to buy)On 1,500 Common Stock3 | -1,500 | - | - | 376,686 direct |
| Dec 3, 2025 | Exercise or conversion of a derivative (M) | Stock Option (right to buy)On 5,000 Common Stock3 | -5,000 | - | - | 371,686 direct |
Holdings before and after
- Stock Option (right to buy): 378,186 to 371,686 direct
Footnotes from the filing
- 1. The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.90 to $3.9112. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- 3. The stock options are fully vested.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Moreadith report in this SER Form 4?
Randall Moreadith (Chief Scientific Officer at Serina Therapeutics Inc., SER) reported that they sold 6,500 shares for $23.5K at an average $3.61, and acquired 6,500 shares at $0.06 between Dec 2, 2025 and Dec 3, 2025. After these transactions the filing shows 0 shares held directly.
How many SER shares does Moreadith hold after this filing?
The filing shows 0 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this SER insider sale made under a 10b5-1 plan?
The filing's footnotes do not mention a Rule 10b5-1 trading plan.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for SER
Earlier insider filings at SER
- Nov 26, 2025Chief Scientific Officer Moreadith Randall exercised 5,965 shares at a strike of $0.06 and sold $23,264 worth of shares (5,965 units at $3.90) (SEC Form 4)
- Nov 26, 2025Chief Scientific Officer Moreadith Randall sold $2,105 worth of shares (535 units at $3.93) and exercised 535 shares at a strike of $0.06 (SEC Form 4)
- Nov 19, 2025Chief Scientific Officer Moreadith Randall exercised 6,500 shares at a strike of $0.06 and sold $24,402 worth of shares (6,500 units at $3.75) (SEC Form 4)
- Nov 12, 2025Chief Scientific Officer Moreadith Randall sold $26,650 worth of shares (6,500 units at $4.10) and exercised 6,500 shares at a strike of $0.06 (SEC Form 4)
- Nov 11, 2025SEC Form 4 filed by Director Brannan Stephen K.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Follow SER and get a push notification the moment its next story breaks.